Chemical modifications of RNA have emerged as a new mechanism for the posttranscriptional regulation of gene expression. While the majority of RNA modifications are methylation events, only a single acetylated ribonucleoside has been described in eukaryotes, occurring at the N4-position of cytidine (N4acetylcytidine, ac4C). In all cases, ac4C production has been catalyzed by the N-acetyltransferase 10 (NAT10) enzyme or its homologs. Studies have indicated that ac4C is associated with RNA stability and translation efficiency. CD Genomics uses acRIP-Seq technology to comprehensively analyze ac4C in the transcriptome.
Figure 1. NAT10 catalyzes cytidine acetylation (Arango,2019)
Basic analysis | Peak Calling analysis Visualization of Peak Statistical analysis of Peak Feature of ac4C Differential Peak analysis Length distribution of acetylation sites and motif analysis GO and Pathway analysis results of differential peak related genes |
Advanced Analytics | Association between RNAseq expression difference and ac4C modification difference Association Analysis of mRNA Variable Splicing and ac4C modification Difference |
The number of cells shall not be less than 2×107.
The quantity of the tissue samples should be between 500 mg - 1g.
The quantity of RNA sample should be no less than 30 μg, RNA purity: OD260/280 = 1.8~2.2; OD260/230 ≥ 1.5; RNA quality: 28S:18S ≥ 1.5, RIN ≥ 7.
CD Genomics is a company that provides professional and comprehensive acRIP-seq services. We have years of experience to meet your specific project needs in using epigenomics research to add value to your research projects. CD Genomics can provide you with personalized solutions to help you thrive every step of the way around your interest in your workflow. If you would like to know more about this service, please feel free to contact us.
Reference
Terms & Conditions Privacy Policy Copyright © CD Genomics. All rights reserved.